Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 6 Months Ended |
Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2017 | Jun. 30, 2016 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 27.6 | $ 27.1 | $ 58.1 | $ 59.5 |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 11.1 | $ 13 | $ 22.1 | $ 26.2 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Common Shares Available for Grant | | 20,900,000 | | 20,900,000 | |
Unrecognized compensation expense | | $ 75.6 | | $ 75.6 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 3 months 18 days | |
Stock Options and SARs [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 26.64 | $ 21.04 |
Expected Volatility (in hundredths) | | | | 30.46% | 35.90% |
Risk-Free Interest Rate (in hundredths) | | | | 1.39% | 0.93% |
Dividend Yield (in hundredths) | | | | 0.68% | 0.91% |
Expected Life (in years) | | | | 5 years 3 months 18 days | 5 years 3 months 18 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 9,850,000 | 10,744,000 |
Granted (in shares) | | | | 16,000 | 11,000 |
Exercised (1) (in shares) | [1] | | | (783,000) | (790,000) |
Forfeited (in shares) | | | | (189,000) | (150,000) |
Outstanding at June 30 (2) (in shares) | [2] | 8,894,000 | 9,815,000 | 8,894,000 | 9,815,000 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 8,594,000 | 9,490,000 | 8,594,000 | 9,490,000 |
Stock Options and SARs Exercisable at June 30 (in shares) | [4] | 4,973,000 | 5,638,000 | 4,973,000 | 5,638,000 |
Intrinsic Value of Stock Options/SARs Exercised | | | | $ 33.5 | $ 26.8 |
Intrinsic Value of Stock Options/SARs Outstanding | | $ 147.8 | $ 173.1 | $ 147.8 | $ 173.1 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding | | | | 3 years 7 months 6 days | 3 years 7 months 6 days |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | | 145.7 | 170.3 | $ 145.7 | $ 170.3 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)al Term | | | | 3 years 6 months | 3 years 7 months 6 days |
Aggregate Intrinsic Value for Exercisable Units | | $ 120.9 | $ 137.7 | $ 120.9 | $ 137.7 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | 2 years 2 months 12 days | 2 years 4 months 24 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 75.53 | $ 67.98 |
Granted (price per share) | | | | 96.41 | 71.51 |
Exercised (1) (price per share) | [1] | | | 57.05 | 44.31 |
Forfeited (price per share) | | | | 89.40 | 85.91 |
Outstanding at June 30 (2) (price per share) | [2] | $ 76.90 | $ 69.61 | 76.90 | 69.61 |
Vested or Expected to Vest (3) (price per share) | [3] | 76.53 | 69.24 | 76.53 | 69.24 |
Exercisable at June 30 (4) (price per share) | [4] | $ 68.43 | $ 61.50 | 68.43 | 61.50 |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 24.28 | $ 17.56 |
Expected Volatility (in hundredths) | | | | 30.33% | 36.79% |
Risk-Free Interest Rate (in hundredths) | | | | 0.65% | 0.49% |
Dividend Yield (in hundredths) | | | | 0.69% | 0.82% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock And Restricted Stock Units [Member] | | | | | |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 15.6 | $ 13.7 | $ 34.2 | $ 32.4 |
Outstanding at January 1 (in shares) | | | | 3,962,000 | 4,908,000 |
Granted (in shares) | | | | 437,000 | 306,000 |
Released (1) (in shares) | [5] | | | (407,000) | (798,000) |
Forfeited (in shares) | | | | (143,000) | (203,000) |
Outstanding at June 30 (2) (in shares) | [6] | 3,849,000 | 4,213,000 | 3,849,000 | 4,213,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 79.63 | $ 70.35 |
Granted (price per share) | | | | 98.97 | 75.56 |
Released (1) (price per share) | [5] | | | 63.20 | 61.36 |
Forfeited (price per share) | | | | 83.92 | 76.97 |
Outstanding at June 30 (2) (price per share) | [6] | $ 83.40 | $ 72.11 | $ 83.40 | $ 72.11 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Intrinsic value released during the year | | | | $ 40.4 | $ 60.8 |
Aggregate intrinsic value of stock and units outstanding | | $ 348.4 | $ 351.5 | 348.4 | 351.5 |
Unrecognized compensation expense | | 151.1 | | $ 151.1 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 6 months | |
Performance Units and Performance Stock [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 0.9 | 0.4 | $ 1.8 | 0.9 |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 545,290 | |
Granted (in shares) | | | | 118,834 | |
Released (1) (in shares) | | | | (89,224) | |
Outstanding at June 30 (2) (in shares) | | 574,900 | | 574,900 | |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Performance Period for Performance Units and Shares | | | | 3 years | |
Minimum Performance Units and Stock Allowed to be Outstanding | | | | 299,540 | |
Minimum Performance Multiple at the Completion of the Performance Period | | | | 0.00% | |
Maximum Performance Multiple at the Completion of the Performance Period | | | | 200.00% | |
Maximum Vest Period from the Date of Grant | | | | 5 years | |
Maximum Performance Units and Stock Allowed to be Outstanding | | | | 850,260 | |
Intrinsic value released during the year | | | | $ 9 | |
Aggregate intrinsic value of stock and units outstanding | | $ 52 | | 52 | |
Unrecognized compensation expense | | 8.6 | | $ 8.6 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 6 months | |
Lease And Well [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 9.6 | 8.9 | $ 20.5 | 19.3 |
Gathering And Processing Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.2 | 0.3 | 0.4 | 0.6 |
Exploration Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 5.3 | 5 | 11.5 | 11.5 |
General And Administrative [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 12.5 | $ 12.9 | $ 25.7 | $ 28.1 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the six months ended JuneĀ 30, 2017 and 2016 was $33.5 million and $26.8 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at JuneĀ 30, 2017 and 2016 was $147.8 million and $173.1 million, respectively. At JuneĀ 30, 2017 and 2016, the weighted average remaining contractual life was 3.6 years and 3.6 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at JuneĀ 30, 2017 and 2016 was $145.7 million and $170.3 million, respectively. At JuneĀ 30, 2017 and 2016, the weighted average remaining contractual life was 3.5 years and 3.6 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at JuneĀ 30, 2017 and 2016 was $120.9 million and $137.7 million, respectively. At JuneĀ 30, 2017 and 2016, the weighted average remaining contractual life was 2.2 years and 2.4 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the six months ended JuneĀ 30, 2017 and 2016 was $40.4 million and $60.8 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at JuneĀ 30, 2017 and 2016 was $348.4 million and $351.5 million, respectively. | |